Lopez Laureen M, Edelman Alison, Chen-Mok Mario, Trussell James, Helmerhorst Frans M
Clinical Sciences, FHI, P.O. Box 13950, Research Triangle Park, North Carolina, USA, 27709.
Cochrane Database Syst Rev. 2011 Apr 13(4):CD008815. doi: 10.1002/14651858.CD008815.pub2.
Progestin-only contraceptives (POCs) are appropriate for many women who cannot or should not take estrogen. Many POCs are long-acting, cost-effective methods of preventing pregnancy. However, concern about weight gain can deter the initiation of contraceptives and cause early discontinuation among users.
The primary objective was to evaluate the association between progestin-only contraceptive use and changes in body weight.
We searched MEDLINE, CENTRAL, POPLINE, EMBASE, LILACS, ClinicalTrials.gov, and ICTRP, and contacted investigators to identify other trials.
All comparative studies were eligible that examined a POC versus another method or no contraceptive. The primary outcome was mean change in body weight or body composition.
Two authors extracted the data. We computed the mean difference with 95% confidence interval (CI) for continuous variables and odds ratio with 95% CI for dichotomous variables.
We did not conduct meta-analysis due to the various contraceptive methods and weight change measures. Fifteen studies examined progestin-only pills (N=1), Norplant (N=4), and depot medroxyprogesterone acetate (DMPA) (N=10). Comparison groups were similar for weight change in 11 studies. Four studies showed differences in weight or body composition change for POCs compared to no hormonal method. Adolescents using DMPA had a greater increase in body fat (%) versus a group using no hormonal method (mean difference 11.00; 95% CI 2.64 to 19.36). The DMPA group also had a greater decrease in lean body mass (%) (mean difference -4.00; 95% CI -6.93 to -1.07). In another study, weight gain (kg) was greater for the DMPA group than an IUD group (mean difference 2.28, 2.71, 3.17, respectively). The differences were notable within the normal weight and overweight subgroups. One study showed the Norplant (six-capsule) group had greater weight gain (kg) than a non-hormonal IUD group (mean difference 0.47 (95% CI 0.29 to 0.65) and a group using non-hormonal or no method (mean difference 0.74; 95% CI 0.52 to 0.96). Another study also showed a Norplant group also had greater weight gain (kg) than an IUD group (mean difference 1.10; 95% CI 0.36 to 1.84).
AUTHORS' CONCLUSIONS: We found little evidence of weight gain when using POCs. Mean gain was less than 2 kg for most studies up to 12 months, and usually similar for the comparison group using another contraceptive. Appropriate counseling about typical weight gain may help reduce discontinuation of contraceptives due to perceptions of weight gain.
仅含孕激素的避孕药(POCs)适用于许多不能或不应服用雌激素的女性。许多POCs是长效、经济有效的避孕方法。然而,对体重增加的担忧可能会阻碍避孕药的使用,并导致使用者提前停药。
主要目的是评估仅含孕激素的避孕药的使用与体重变化之间的关联。
我们检索了医学文献数据库(MEDLINE)、考克兰系统评价数据库(CENTRAL)、人口与健康数据库(POPLINE)、荷兰医学文摘数据库(EMBASE)、拉丁美洲和加勒比卫生科学数据库(LILACS)、临床试验注册库(ClinicalTrials.gov)和国际临床试验注册平台(ICTRP),并联系研究人员以识别其他试验。
所有比较研究均符合条件,这些研究比较了一种POC与另一种方法或不使用避孕药的情况。主要结局是体重或身体成分的平均变化。
两位作者提取数据。对于连续变量,我们计算了95%置信区间(CI)的平均差值;对于二分变量,我们计算了95%CI的比值比。
由于避孕方法和体重变化测量方法的多样性,我们未进行荟萃分析。15项研究考察了单纯孕激素片(N = 1)、皮下埋植剂(Norplant,N = 4)和醋酸甲羟孕酮长效避孕针(DMPA,N = 10)。在11项研究中,比较组的体重变化相似。4项研究表明,与不使用激素方法相比,POCs在体重或身体成分变化方面存在差异。使用DMPA的青少年与不使用激素方法的组相比,体脂增加百分比更大(平均差值11.00;95%CI 2.64至19.36)。DMPA组的去脂体重百分比下降也更大(平均差值 -4.0;95%CI -6.93至 -1.07)。在另一项研究中,DMPA组的体重增加(kg)比宫内节育器(IUD)组更大(平均差值分别为2.28、2.71、3.17)。这些差异在正常体重和超重亚组中较为显著。一项研究表明,皮下埋植剂(六根型)组的体重增加(kg)比非激素IUD组更大(平均差值0.47(95%CI 0.29至0.65)),也比使用非激素或不使用任何方法的组更大(平均差值0.74;95%CI 0.52至0.96)。另一项研究也表明,皮下埋植剂组的体重增加(kg)比IUD组更大(平均差值1.10;95%CI 0.36至1.84)。
我们发现使用POCs时几乎没有体重增加的证据。在大多数长达12个月的研究中,平均体重增加小于2kg,并且通常与使用另一种避孕药的比较组相似。关于典型体重增加的适当咨询可能有助于减少因担心体重增加而导致的避孕药停药情况。